Trial Profile
Phase III trial of TZ 101 in patients with leukaemia or lymphoma undergoing haematopoietic stem cell transplantation
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 27 Apr 2015
Price :
$35
*
At a glance
- Drugs TZ 101 (Primary)
- Indications Leukaemia; Lymphoma
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Targazyme
- 27 Apr 2015 New trial record